Lord, Abbett & Co. LLC Mirati Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.6 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $1.51 Million - $2.2 Million	-25,349 Reduced 8.09%	287,946 $20.1 Million
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $196,191 - $444,437	5,010 Added 1.63%	313,295 $21 Million
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $14.3 Million - $28.6 Million	-189,155 Reduced 38.03%	308,285 $25.3 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $3.08 Million - $4.44 Million	23,349 Added 4.93%	497,440 $73 Million
Q3 2021 Nov 09, 2021	BUY	$132.13 - $177.45 $15.4 Million - $20.7 Million	116,561 Added 32.6%	474,091 $83.9 Million
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $37.8 Million - $47.2 Million	-262,793 Reduced 42.36%	357,530 $57.8 Million
Q1 2021 May 11, 2021	SELL	$158.92 - $221.61 $22.2 Million - $31 Million	-139,798 Reduced 18.39%	620,323 $106 Million
Q4 2020 Feb 09, 2021	BUY	$162.05 - $240.27 $59.1 Million - $87.6 Million	364,634 Added 92.2%	760,121 $167 Million
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $28.8 Million - $42.5 Million	-253,968 Reduced 39.1%	395,487 $65.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $1.5 Million - $2.51 Million	-20,810 Reduced 3.1%	649,455 $74.1 Million
Q1 2020 May 14, 2020	SELL	$69.78 - $116.21 $3.3 Million - $5.5 Million	-47,294 Reduced 6.59%	670,265 $51.5 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $23.4 Million - $42.7 Million	331,376 Added 85.81%	717,559 $92.5 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $739,521 - $1.04 Million	9,492 Added 2.52%	386,183 $30.1 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $15.1 Million - $26.6 Million	-253,693 Reduced 40.24%	376,691 $38.8 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $15.9 Million - $28.7 Million	364,005 Added 136.65%	630,384 $46.2 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $207,552 - $307,630	6,486 Added 2.5%	266,379 $11.3 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $12.2 Million - $16.3 Million	259,893 New	259,893 $12.2 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account